Cost effectiveness

Cost effectiveness is an important aspect of commissioning, because it compares the cost of a health intervention alongside the outcome, which helps commissioners to allocate resources effectively.

Our Cost effectiveness Blogs

Is third-wave CBT good value?

1 Response »
Profile photo of Christopher Sampson
Posted by
thought-catalog-674419-unsplash

Chris Sampson summarises a systematic review on the economic impact of third-wave cognitive behavioural therapies, such as mindfulness-based cognitive therapy, acceptance and commitment therapy, extended behavioural activation, dialectical behaviour therapy, and mindfulness-based stress reduction.

[read the full story...]

Collaborative care for depression and physical multimorbidity: clinically and cost-effective over the long term

No Responses »
Profile photo of Gemma_Shields
Posted by
rawpixel-587848-unsplash

Gemma Shields summarises the findings of a cluster RCT looking at the long-term clinical and cost-effectiveness of collaborative care (versus usual care) for people with mental-physical multimorbidity.

[read the full story...]

Incredible Years Teacher Classroom Management: STARS trial suggests benefits for children’s mental health

1 Response »
Profile photo of Neil Humphrey
Posted by
rawpixel-660721-unsplash (1)

Neil Humphrey is impressed by the STARS cluster randomised controlled trial published today in Psychological Medicine, which evaluates the effectiveness and cost-effectiveness of the Incredible Years Teacher Classroom Management programme in primary school children.

[read the full story...]

Periodontal health: no additional benefit from 6 monthly Scale and Polish

1 Response »
Profile photo of Derek Richards
Posted by
shutterstock_2584741

This large multicentre, cluster randomised controlled compared the clinical effectiveness and cost-effectiveness of theory-based, personalised oral hygiene advice or scale and polish’ with routine care in improving periodontal health in dentate adults attending general dental practice.

[read the full story...]

Person-centred care for dementia: impact on quality of life, agitation and antipsychotic use

2 Responses »
Profile photo of Hilary Shepherd
Posted by
4084079896_8eb54c3e0c_o

Hilary Shepherd reports on a recent paper from the WHELD trial on the impact of person-centred care training and person-centred activities on quality of life, agitation, and antipsychotic use in people with dementia living in nursing homes.

[read the full story...]

iCBT for OCD in young people: study suggests it’s cost-effective, but more research needed

No Responses »
Profile photo of Alastair Canaway
Posted by
pexels-photo-248029

Alastair Canaway on a recent RCT that looks at the cost-effectiveness of therapist-guided internet-delivered cognitive behaviour therapy for paediatric obsessive–compulsive disorder.

[read the full story...]

Early intervention in psychosis services: better outcomes, improved costs

1 Response »
Profile photo of Gemma_Shields
Posted by
4293345631_584b606487_o

Gemma Shields reports on a recent longitudinal retrospective controlled study of the economic impact of early intervention in psychosis services in England.

[read the full story...]

Reminiscence groups for people with dementia and their family carers: REMCARE trial

48 Responses »
Profile photo of Elizabeth Collier
Posted by
photo-256887_1280

Elizabeth Collier writes her debut blog on the REMCARE randomised controlled trial of reminiscence groups for people with dementia and their family carers.

[read the full story...]

Specialist depression service may help people with persistent depression

33 Responses »
Profile photo of Ben Hannigan
Posted by
photo-1461783436728-0a9217714694

Ben Hannigan reports on a recent RCT of the efficacy and cost-effectiveness of a specialist depression service versus usual specialist mental health care to manage persistent depression.

[read the full story...]

The case for investing in anxiety and depression treatment on a global scale

65 Responses »
Profile photo of Christopher Sampson
Posted by
5556025283_6e385643dc_o

Chris Sampson looks at a major new economic study into the return on investment of increased coverage for anxiety and depression treatment.

[read the full story...]